Pulmatrix (PULM) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. ABBV
7. MRVL
8. CL
9. CHKP
10. ORCL

Go back to Pulmatrix (PULM) Tops Q3 EPS by 6c

Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update

November 10, 2022 9:05 AM EST

PUR1900 (Pulmazole) on track for Phase 2 study start in Q1 2023

PUR3100 Phase 1 study top line data anticipated in early Q1 2023

$40.7 million in cash and cash equivalents at end of Q3 2022

LEXINGTON, Mass., Nov. 10, 2022 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address... More